KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EPS (Weighted Average and Diluted): 2019-2025

Historic EPS (Weighted Average and Diluted) for Moderna (MRNA) over the last 6 years, with Sep 2025 value amounting to -$0.51.

  • Moderna's EPS (Weighted Average and Diluted) fell 1800.00% to -$0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.07, marking a year-over-year decrease of 38.90%. This contributed to the annual value of -$9.28 for FY2024, which is 24.74% up from last year.
  • Latest data reveals that Moderna reported EPS (Weighted Average and Diluted) of -$0.51 as of Q3 2025, which was up 76.06% from -$2.13 recorded in Q2 2025.
  • Moderna's 5-year EPS (Weighted Average and Diluted) high stood at $11.29 for Q4 2021, and its period low was -$9.53 during Q3 2023.
  • For the 3-year period, Moderna's EPS (Weighted Average and Diluted) averaged around -$2.44, with its median value being -$2.52 (2025).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 2,183.87% in 2021, then tumbled by 1,800.00% in 2025.
  • Quarterly analysis of 5 years shows Moderna's EPS (Weighted Average and Diluted) stood at $11.29 in 2021, then crashed by 67.58% to $3.66 in 2022, then crashed by 84.70% to $0.56 in 2023, then crashed by 619.64% to -$2.91 in 2024, then tumbled by 1,800.00% to -$0.51 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.51 for Q3 2025, versus -$2.13 for Q2 2025 and -$2.52 for Q1 2025.